Le réseau international des cancers rares (RCN, Rare Cancer Network)

2014 ◽  
Vol 101 (9) ◽  
pp. 778-779 ◽  
Author(s):  
René-Olivier Mirimanoff ◽  
Juliette Thariat ◽  
Yazid Belkacemi ◽  
Salvodor Villa ◽  
Enis Ozyar ◽  
...  
Keyword(s):  
Rare Cancer ◽  
Cancer Network ◽  
Réseau International ◽  
Cancers Rares

Outcome and Prognostic Factors in Endometrial Stromal Tumors: A Rare Cancer Network Study

2012 ◽  
Vol 82 (5) ◽  
pp. e757-e763 ◽  
Author(s):  
Ulrike Schick ◽  
Yasmin Bolukbasi ◽  
Juliette Thariat ◽  
Roxolyana Abdah-Bortnyak ◽  
Abraham Kuten ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Rare Cancer ◽  
Stromal Tumors ◽  
Cancer Network ◽  
Endometrial Stromal Tumors

scholarly journals Radiotherapy for marginally resected, unresectable or recurrent giant cell tumor of the bone: a rare cancer network study

Rare Tumors ◽  
2011 ◽  
Vol 3 (4) ◽  
pp. 150-152 ◽  
Author(s):  
Sumita Bhatia ◽  
Leszek Miszczyk ◽  
Martine Roelandts ◽  
Tan Dat Nguyen ◽  
Tom Boterberg ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Giant Cell ◽  
Local Control ◽  
Symptom Relief ◽  
Significant Proportion ◽  
Rare Cancer ◽  
Giant Cell Tumors ◽  
Number Of Patients ◽  
Cancer Network

The role of radiotherapy for local control of marginally resected, unresectable, and recurrent giant cell tumors of bone (GCToB) has not been well defined. The number of patients affected by this rare disease is low. We present a series of 58 patients with biopsy proven GCToB who were treated with radiation therapy. A retrospective review of the role of radiotherapy in the treatment of GCToB was conducted in participating institutions of the Rare Cancer Network. Eligibility criteria consisted of the use of radiotherapy for marginally resected, unresectable, and recurrent GCToB. Fifty-eight patients with biopsy proven GCToB were analyzed from 9 participating North American and European institutions. Forty-five patients had a primary tumor and 13 patients had a recurrent tumor. Median radiation dose was 50 Gy in a median of 25 fractions. Indication for radiation therapy was marginal resection in 33 patients, unresectable tumor in 13 patients, recurrence in 9 patients and palliation in 2 patients. Median tumor size was 7.0 cm. A significant proportion of the tumors involved critical structures. Median follow-up was 8.0 years. Five year local control was 85%. Of the 7 local failures, 3 were treated successfully with salvage surgery. All patients who received palliation achieved symptom relief. Five year overall survival was 94%. None of the patients experienced grade 3 or higher acute toxicity. This study reports a large published experience in the treatment of GCToB with radiotherapy. Radiotherapy can provide excellent local control for incompletely resected, unresectable or recurrent GCToB with acceptable morbidity.

Outcome and prognostic factors in primary uterine leiomyosarcoma: a rare cancer network study

2001 ◽  
Vol 37 ◽  
pp. S328
Author(s):  
A. Franzetti-Pellanda ◽  
E. Deniaud-Alexandre ◽  
M. Krengli ◽  
P. Van Houtte ◽  
A. Richetti ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Uterine Leiomyosarcoma ◽  
Rare Cancer ◽  
Cancer Network

Outcome and prognostic factors of phyllodes tumor of the breast: A rare cancer network study

2004 ◽  
Vol 60 ◽  
pp. S209-S209
Author(s):  
Y BELKACEMI ◽  
G BOUSQUET ◽  
I RAYCOQUART ◽  
N MAGNE ◽  
Y MALARD ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Phyllodes Tumor ◽  
Rare Cancer ◽  
Cancer Network

The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: A rare cancer network retrospective study

2005 ◽  
Vol 77 (3) ◽  
pp. 286-289 ◽  
Author(s):  
Tan Dat Nguyen ◽  
Philip M.P. Poortmans ◽  
Marleen van der Hulst ◽  
Gabriela Studer ◽  
Eva Pigois ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Rare Cancer ◽  
Adenocarcinoma Of The Prostate ◽  
Cancer Network

Primary prostatic sarcomas: A large multidisciplinary Rare Cancer Network study

2016 ◽  
Vol 15 (13) ◽  
pp. e1647-e1649
Author(s):  
B. De Bari ◽  
B. Stish ◽  
Y. Habboush ◽  
P. Sargos ◽  
M. Krengli ◽  
...  
Keyword(s):  
Rare Cancer ◽  
Cancer Network

Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study

2012 ◽  
Vol 82 (1) ◽  
pp. 315-320 ◽  
Author(s):  
Yavuz Anacak ◽  
Robert C. Miller ◽  
Nikos Constantinou ◽  
Angela M. Mamusa ◽  
Ron Epelbaum ◽  
...  
Keyword(s):  
Salivary Glands ◽  
Lymphoid Tissue ◽  
Rare Cancer ◽  
Cancer Network
Sign in / Sign up

Export Citation Format

Share Document